AlphaCentric Robotics and Automation C (GNXCX)

12.43 -0.09  -0.72% Jul 7 USD
View Full Chart
Total Returns Chart

Key Stats

Net Asset Value 12.43
Turnover Ratio 315.0%
1 Year Fund Level Flows 5.054M

Performance & Returns

  Total Return Cat. Total Return (NAV) % Rank in Cat. (NAV)
1M -3.04% -1.58% 59
3M 31.95% 24.96% 22
6M 5.34% -6.78% 16
YTD 5.34% -6.69% 18
1Y 8.46% 0.07% 34
3Y 9.56% 4.55% 24
5Y -- 5.48% --
10Y -- 8.43% --
15Y -- 6.76% --
20Y -- 5.21% --
As of July 7, 2020. Returns for periods of 1 year and above are annualized.

Asset Allocation

Type % Net % Long % Short
Cash 5.86% 5.86% 0.00%
Stock 94.14% 94.14% 0.00%
Bond 0.00% 0.00% 0.00%
Convertible 0.00% 0.00% 0.00%
Preferred 0.00% 0.00% 0.00%
Other 0.00% 0.00% 0.00%
As of March 31, 2020

Region Exposure

Americas 51.85%
North America 51.85%
Latin America 0.00%
Greater Europe 19.28%
United Kingdom 1.61%
Europe Developed 17.67%
Europe Emerging 0.00%
Africa/Middle East 0.00%
Greater Asia 28.87%
Japan 23.46%
Australasia 0.16%
Asia Developed 5.24%
Asia Emerging 0.00%
Market Classification
% Developed Markets 100.0%
% Emerging Markets 0.00%
As of March 31, 2020. Region breakdown data is calculated by using the long position holdings of the portfolio.

Stock Sector Exposure

Basic Materials 0.00%
Communication Services 0.00%
Consumer Cyclical 0.00%
Consumer Defensive 0.00%
Energy 0.00%
Financial Services 0.00%
Healthcare 27.85%
Industrials 38.12%
Real Estate 0.00%
Technology 34.04%
Utilities 0.00%
As of March 31, 2020

Stock Market Capitalization

Giant 5.86%
Large 23.99%
Medium 35.50%
Small 17.32%
Micro 17.33%
As of March 31, 2020

Stock Style Exposure

Large Cap Value 0.00%
Large Cap Blend 17.09%
Large Cap Growth 14.50%
Mid Cap Value 2.79%
Mid Cap Blend 8.54%
Mid Cap Growth 26.26%
Small Cap Value 6.68%
Small Cap Blend 2.57%
Small Cap Growth 21.58%
As of March 31, 2020
View More Holdings

Top 10 Holdings

Symbol Name % Weight Price % Chg
ISRG Intuitive Surgical Inc 3.82% 580.69 +0.93%
6383 Daifuku Co Ltd 3.67% -- --
TECN Tecan Group Ltd 3.48% -- --
BTAI BioXcel Therapeutics Inc 3.45% 53.00 +6.04%
6324 Harmonic Drive Systems Inc 3.38% -- --
6861 Keyence Corp 3.11% -- --
NOVT Novanta Inc 3.08% 103.54 +0.56%
6645 OMRON Corp 3.02% -- --
BRKS Brooks Automation Inc 2.94% 44.97 +2.93%
STXS Stereotaxis Inc 2.91% 4.19 -4.34%
As of March 31, 2020
Advertisement

Basic Info

Investment Strategy
The investment seeks long-term capital appreciation. The fund seeks to achieve its investment objective by investing in a portfolio of U.S. and foreign common stock of companies involved in innovative and breakthrough technologies across multiple sectors. Under normal market conditions, the fund invests at least 80% of its net assets plus any borrowings for investment purposes in companies involved in robotics-related and/or automation-related products and/or services. The fund is non-diversified.
General
Security Type Mutual Fund
Oldest Share Symbol GNXIX
Equity Style Mid Cap/Growth
Fixed Income Style --
Broad Asset Class International Equity
Broad Category Equity
Category Name World Small/Mid Stock
Prospectus Objective Specialty - Technology
Fund Owner Firm Name AlphaCentric Funds
Benchmark Index
S&P 500 TR USD 100.0%
Reports
One Page Report Download

Manager Info

Name Tenure
Brian Gahsman 3.04 yrs

Share Classes

Symbol Share Class
GNXAX A
GNXIX Inst

Net Fund Flows

1M 232135.2
3M -994069.4
6M -1.389M
YTD -1.389M
1Y 5.054M
3Y 30.20M
5Y --
10Y --
As of June 30, 2020

Risk Info

Beta (5Y) --
Historical Sharpe Ratio (10Y) --
Historical Sortino (All) 0.5524
Daily Value at Risk (VaR) 1% (All) 3.45%
Monthly Value at Risk (VaR) 1% (All) 25.23%

Fundamentals

Dividend Yield TTM (7-7-20) 0.00%
30-Day SEC Yield --
7-Day SEC Yield --
Weighted Average PE Ratio 27.91
Weighted Average Price to Sales Ratio 2.285
Weighted Average Price to Book Ratio 3.334
Weighted Median ROE 11.16%
Weighted Median ROA 1.24%
Forecasted Dividend Yield 1.20%
Forecasted PE Ratio 21.91
Forecasted Price to Sales Ratio 2.111
Forecasted Price to Book Ratio 2.674
Number of Holdings 40
As of March 31, 2020

Growth Estimates

Forecasted 5 Yr Earnings Growth 9.99%
Forecasted Book Value Growth 1.06%
Forecasted Cash Flow Growth -2.96%
Forecasted Earnings Growth 8.28%
Forecasted Revenue Growth 1.14%
As of March 31, 2020

Comparables

Edit

Attributes

Purchase Details
Open to New Investors Yes
Open to Existing Investors Yes
Minimum Initial Investment 2500.00 USD
Minimum Subsequent Investment 100.00 USD
Fees
Actual 12B-1 Fee 1.00%
Actual Management Fee 1.25%
Administration Fee --
Performance Fee --
Switching Fee --
Transaction Fee --
Maximum Front Load --
Maximum Deferred Load --
Maximum Redemption Fee --
Key Dates
Inception Date 5/31/2017
Termination Date
Last Annual Report Date 3/31/2020
Last Prospectus Date 8/1/2019
Attributes
Exchange Traded Share No
Exchange Traded Note No
Enhanced Index Fund No
Fixed Distribution Fund No
High-Net Worth Individual Fund No
Index Fund No
Inverse Fund No
Leveraged Fund No
Fund of Funds No
Currency Hedged Fund No
Synthetic Replication Fund No
Has Dividend Investment Plan No
Socially Responsible Fund No
General Availability
Available for Insurance Product No
Available for Retirement Plan No
Available for RRSP No
Advertisement

{{root.upsell.info.feature_headline}}.

{{root.upsell.info.feature_description}}

Please note that this feature is only available as an add-on to YCharts subscriptions.


Please note that this feature requires full activation of your account and is not permitted during the free trial period.

Start My Free Trial {{root.upsell.info.call_to_action}} No credit card required.

Already a subscriber? Sign in.